Related by context. Frequent words. (Click for all words.) 67 INCB# [002] 67 XL# [003] 67 Phase 2b trial 67 Phase 2b study 67 panitumumab 66 carfilzomib 66 Phase Ib 65 Phase 1b 65 Vectibix 65 perifosine 65 Phase 2b clinical 65 MGCD# [001] 64 MDV# 64 sunitinib 64 FOLOTYN 64 daclizumab 64 temozolomide 64 gemcitabine 64 monotherapy 64 sorafenib 64 RAD# [003] 64 ACTEMRA 64 Phase 2a 63 pralatrexate 63 investigational compound 63 ASA# 63 ISIS # 63 Phase 2a clinical 63 ADVEXIN 63 PRX # 63 RDEA# 63 Genasense 62 ofatumumab 62 dose escalation study 62 AP# [003] 62 FTY# 62 Phase IIa trial 62 erlotinib 62 mg dose 62 Vidaza 62 mipomersen 62 T DM1 62 docetaxel 61 telbivudine 61 Phase IIa clinical 61 Tarceva 61 ambrisentan 61 AZD# 61 CYT# 61 pharmacodynamic 61 Phase IIb trial 61 VELCADE 61 LymphoStat B 61 gefitinib 61 Phase IIb clinical 61 etanercept 60 TMC# [001] 60 bevacizumab 60 dasatinib 60 picoplatin 60 ENBREL 60 tivozanib 60 brentuximab vedotin 60 SEROQUEL 60 elesclomol 60 dose escalation 60 hormone refractory prostate cancer 60 lapatinib 60 Phase 2b 60 G CSF 60 PLX# 60 relapsing remitting multiple sclerosis 60 pivotal Phase III 60 maraviroc 60 eculizumab 60 linaclotide 60 Phase IIb 60 lubiprostone 60 tolerability 60 cetuximab 60 Selzentry 60 Clolar 59 satraplatin 59 Phase III clinical 59 voreloxin 59 laquinimod 59 PEGINTRON 59 sitagliptin 59 CRx 59 antitumor activity 59 Ceplene 59 rosuvastatin 59 JANUVIA 59 protease inhibitor 59 citalopram 59 Alpharadin 59 exenatide 59 tolerability profile 59 pegylated interferon 59 investigational drug 59 capecitabine